Sepiapterin reductase inhibition selectively reduces inflammatory joint pain and increases urinary sepiapterin in the late phase.
暂无分享,去创建一个
Alban Latremoliere | M. Costigan | B. L. Turnes | Masahide Fujita | Débora da Luz Scheffer | Shane J. F. Cronin | J. Clifford | Woolf | Alexandra Latini | Nick A. Andrews | Shane J. F. Cronin
[1] E. McNeill,et al. The metabolite BH4 controls T cell proliferation in autoimmunity and cancer , 2018, Nature.
[2] D. Hafler,et al. Regulatory T cells in autoimmune disease , 2018, Nature Immunology.
[3] M. Persson,et al. Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: a meta-analysis of randomized controlled trials , 2018, Rheumatology.
[4] D. Geschwind,et al. Mechanistic Differences in Neuropathic Pain Modalities Revealed by Correlating Behavior with Global Expression Profiling , 2018, Cell reports.
[5] L. Barbeito,et al. Neopterin as a potential cytoprotective brain molecule. , 2015, Journal of psychiatric research.
[6] J. Friedman,et al. Urine sepiapterin excretion as a new diagnostic marker for sepiapterin reductase deficiency. , 2015, Molecular genetics and metabolism.
[7] K. Channon,et al. Reduction of Neuropathic and Inflammatory Pain through Inhibition of the Tetrahydrobiopterin Pathway , 2015, Neuron.
[8] S. Hwang,et al. Bacteria activate sensory neurons that modulate pain and inflammation , 2013, Nature.
[9] K. Johnsson,et al. Tetrahydrobiopterin Biosynthesis as an Off-Target of Sulfa Drugs , 2013, Science.
[10] Kutty Selva Nandakumar,et al. Collagen antibody-induced arthritis evokes persistent pain with spinal glial involvement and transient prostaglandin dependency. , 2012, Arthritis and rheumatism.
[11] C. Woolf,et al. Analgesia by inhibiting tetrahydrobiopterin synthesis. , 2012, Current opinion in pharmacology.
[12] E. Werner,et al. Tetrahydrobiopterin: biochemistry and pathophysiology. , 2011, The Biochemical journal.
[13] K. Johnsson,et al. A yeast-based screen reveals that sulfasalazine inhibits tetrahydrobiopterin biosynthesis. , 2011, Nature chemical biology.
[14] Tsutomu Takeuchi,et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update , 2010, Annals of the rheumatic diseases.
[15] H. Sawada,et al. Expression analysis of the aldo-keto reductases involved in the novel biosynthetic pathway of tetrahydrobiopterin in human and mouse tissues. , 2009, Journal of biochemistry.
[16] Kutty Selva Nandakumar,et al. Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis. , 2005, Journal of immunological methods.
[17] H. Ishida,et al. N-Acetyltransferase 2 Genotype-Related Efficacy of Sulfasalazine in Patients with Rheumatoid Arthritis , 2004, Pharmaceutical Research.
[18] Kutty Selva Nandakumar,et al. Collagen antibody induced arthritis. , 2007, Methods in molecular medicine.